Catalog Number: |
D01000 |
|
CAS No.: |
1195765-45-7 |
MDL: |
|
|
Formula: |
C23H20F3N5O2S2 |
F.W.: |
519.57 |
|
Purity: |
99% |
Package: |
|
|
Unit: |
mg |
Appearance: |
|
|
M.P.: |
|
B.P.: |
|
|
Density: |
|
Optical Rotation: |
|
|
Refractive Index: |
|
Solubility: |
Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
|
Stability: |
|
Storage: |
Amber Vial, -20°C Freezer, Under inert atmosphere |
|
Category: |
Reference Standard |
Reference: |
Hauschild, A., et al.: Lancet, 380, 358 (2012); Falchook, G.S., et al.: Lancet, 379, 1893 (2012); Ascierto, P.A., et al.: J. Clin. Oncol., 31, 3205 (2013) |
Application: |
Dabrafenib is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma. |
Category: |
Amines, Aromatics, Heterocycles, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals, Sulfur & Selenium Compounds |